Replies to post #197529 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Missling has been raising money all along to keep about $20m in cash. I see no difference to that cash flow principle now, except the burn rate is increasing with the ongoing trials and correspondingly more cash has to be raise to keep that same buffer.

[Jonjones325]

If the data is not so hot in P3 then we’re all in trouble and he’d better be raising money much faster than this. The fact that he isn’t hints that it is going well. Otherwise you would see him making or trying to make deals quickly. Especially since read outs are coming up.

There’s gotta be some out-licensing opportunities given all of our preclinical data in various indications. BPs have money to throw around. Why not throw some our way to see if anything sticks?

Is Missling being greedy, smart or stupid? It seems like he’s going all in with conviction. He threw all the chips in and is now standing up at the table to see what the trials reveal. For someone so cautious in all of his prior moves, it seems like quite a gamble.

Unless it’s not. “When you look back and see why we did what we did, you will understand why.”